Sorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II study

Auteurs

F Mouriaux, V Servois, J J Parienti, T Lesimple, A Thyss, C Dutriaux, E M Neidhart-Berard, N Penel, C Delcambre, L Peyro Saint Paul, A D Pham, N Heutte, S Piperno-Neumann, F Joly